Correlation Between Systemair and Pharmiva

Can any of the company-specific risk be diversified away by investing in both Systemair and Pharmiva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Systemair and Pharmiva into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Systemair AB and Pharmiva AB, you can compare the effects of market volatilities on Systemair and Pharmiva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Systemair with a short position of Pharmiva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Systemair and Pharmiva.

Diversification Opportunities for Systemair and Pharmiva

0.0

Correlation Coefficient

Systemair  Pharmiva

Pay attention - limited upside

The 3 months correlation between Systemair and Pharmiva is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Systemair AB and Pharmiva AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmiva AB and Systemair is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Systemair AB are associated (or correlated) with Pharmiva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmiva AB has no effect on the direction of Systemair i.e., Systemair and Pharmiva go up and down completely randomly.

Pair Corralation between Systemair and Pharmiva

If you would invest  8,780  in Systemair AB on September 20, 2024 and sell it today you would earn a total of  490.00  from holding Systemair AB or generate 5.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Systemair AB  vs.  Pharmiva AB

Systemair AB

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Systemair AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Systemair may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pharmiva AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pharmiva AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Pharmiva is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Systemair and Pharmiva

The main advantage of trading using opposite Systemair and Pharmiva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Systemair position performs unexpectedly, Pharmiva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmiva will offset losses from the drop in Pharmiva's long position.

The idea behind Systemair AB and Pharmiva AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.